Patents by Inventor Frederik Defesche

Frederik Defesche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ZIPRASIDONE FORMULATIONS
    Publication number: 20250049709
    Abstract: Provided is an aqueous formulation of ziprasidone, stored for up to six months at 40° C., suitable for intramuscular injection. In these embodiments, the aqueous formulation (a) provides greater than 98% purity of the ziprasidone and/or (b) has less than 0.5% of USP Related Compound C with respect to ziprasidone. Also provided is a method of administering ziprasidone to a patient, the method comprising administering the above formulation to the patient intramuscularly through a syringe.
    Type: Application
    Filed: December 9, 2022
    Publication date: February 13, 2025
    Applicant: BELOTECA, INC.
    Inventors: Frederik Defesche, Dorla Mirejovsky, Cristiane Marcondes Messora Barion
  • CETRORELIX INJECTABLE LIQUID FORMULATION
    Publication number: 20230338277
    Abstract: Provided is an aqueous formulation comprising cetrorelix and/or a salt thereof, an isotonicity adjuster, a pH adjuster and water, suitable for subcutaneous injection. Also provided is a method of treating a patient with cetrorelix comprising injecting the above aqueous formulation to the patient in a manner sufficient to treat the patient.
    Type: Application
    Filed: April 20, 2023
    Publication date: October 26, 2023
    Applicant: BELOTECA, INC.
    Inventors: Frederik Defesche, Dorla Mirejovsky, Jenny Tran